NCT03236857 2023-05-22A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesAbbViePhase 1 Completed143 enrolled
NCT00006480 2010-09-21Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory NeuroblastomaFred Hutchinson Cancer CenterPhase 1 Completed